Princeton, NJ, United States of America

Lakshama Samala

USPTO Granted Patents = 3 


 

Average Co-Inventor Count = 8.8

ph-index = 2

Forward Citations = 17(Granted Patents)


Company Filing History:


Years Active: 2010-2014

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Lakshama Samala

Introduction

Lakshama Samala is a notable inventor based in Princeton, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the area of serotonin-mediated diseases and disorders. With a total of 3 patents to his name, Samala's work is recognized for its potential impact on medical treatments.

Latest Patents

Samala's latest patents include innovative compounds aimed at addressing critical health issues. One of his patents focuses on "Tryptophan hydroxylase inhibitors," which discloses compounds of formulae I and II, along with compositions that can be used to treat, prevent, and manage serotonin-mediated diseases and disorders. Another significant patent is for "Multicyclic amino acid derivatives," which also includes compounds of formulae I and II, and outlines methods for their use in similar therapeutic applications.

Career Highlights

Lakshama Samala is currently associated with Lexicon Pharmaceuticals, Inc., where he continues to advance his research and development efforts. His work is characterized by a commitment to innovation and a focus on improving patient outcomes through novel therapeutic approaches.

Collaborations

Some of his notable coworkers include Arokiasamy Devasagayaraj and Haihong Jin, who contribute to the collaborative environment at Lexicon Pharmaceuticals, Inc. Their combined expertise enhances the potential for groundbreaking discoveries in the pharmaceutical industry.

Conclusion

Lakshama Samala's contributions to the field of pharmaceuticals through his patents and collaborative efforts highlight his role as an influential inventor. His work continues to pave the way for advancements in the treatment of serotonin-mediated diseases and disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…